Beyond HumanBig PictureCatalystsConnected WorldExchangeMarketing MixNew MoneyNew SchoolPeople SciencePulse

AI will play a complex role in the future of drug discovery: Here’s why

Roy Smythe

With AI identifying potential therapies, it could actually be adding to the problem of the pharmaceutical backlog. But could it also be used to solve the problem it helped create?

AI has the power to mine patient data that could transform the inefficient clinical trial system, but is its ability to discover new therapies adding to the problem of the therapy backlog?

Roy Smythe, Chief Medical Officer, Strategy and Partnerships for Philips, reveals how AI is both part of the pipeline problem, and the solution.

This interview is part of ‘The Age of Transformation – How Pharma Can Harness the Power of Data’, a series powered by Medidata.